Amprius Technologies (NYSE:AMPX – Get Free Report) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Tuesday,Zacks.com reports.
Several other equities research analysts have also recently commented on AMPX. Northland Securities set a $24.00 target price on Amprius Technologies in a research note on Monday, May 11th. Roth Capital reaffirmed a “buy” rating on shares of Amprius Technologies in a research note on Friday, May 8th. JonesTrading initiated coverage on Amprius Technologies in a report on Friday, July 10th. They issued a “buy” rating and a $30.00 price target on the stock. Clear Str started coverage on Amprius Technologies in a research report on Tuesday, June 2nd. They issued a “strong-buy” rating and a $33.00 price objective for the company. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Amprius Technologies in a report on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $22.50.
Get Our Latest Analysis on AMPX
Amprius Technologies Stock Up 9.2%
Amprius Technologies (NYSE:AMPX – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The firm had revenue of $28.54 million for the quarter, compared to analyst estimates of $25.72 million. Amprius Technologies had a negative return on equity of 13.23% and a negative net margin of 35.16%. On average, equities analysts expect that Amprius Technologies will post -0.07 earnings per share for the current year.
Insider Buying and Selling
In other Amprius Technologies news, Director Kang Sun sold 67,796 shares of the stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $14.79, for a total value of $1,002,702.84. Following the transaction, the director owned 1,280,854 shares of the company’s stock, valued at approximately $18,943,830.66. This represents a 5.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Donald R. Dixon sold 85,000 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $17.17, for a total value of $1,459,450.00. Following the completion of the transaction, the director directly owned 359,380 shares in the company, valued at $6,170,554.60. The trade was a 19.13% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 310,144 shares of company stock valued at $5,049,997 over the last 90 days. Company insiders own 5.10% of the company’s stock.
Institutional Trading of Amprius Technologies
A number of hedge funds have recently modified their holdings of the company. Oppenheimer & Co. Inc. increased its holdings in Amprius Technologies by 47.7% during the 4th quarter. Oppenheimer & Co. Inc. now owns 442,090 shares of the company’s stock worth $3,488,000 after purchasing an additional 142,751 shares in the last quarter. Stephens Investment Management Group LLC boosted its position in shares of Amprius Technologies by 33.1% during the fourth quarter. Stephens Investment Management Group LLC now owns 1,441,698 shares of the company’s stock worth $11,375,000 after buying an additional 358,791 shares during the period. Hussman Strategic Advisors Inc. bought a new position in shares of Amprius Technologies during the fourth quarter worth about $1,657,000. Vanguard Group Inc. lifted its stake in Amprius Technologies by 9.5% in the 4th quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company’s stock valued at $56,245,000 after acquiring an additional 616,037 shares in the last quarter. Finally, UBS Group AG boosted its position in Amprius Technologies by 35.5% during the 4th quarter. UBS Group AG now owns 2,098,946 shares of the company’s stock worth $16,561,000 after acquiring an additional 549,892 shares during the last quarter. 5.04% of the stock is currently owned by institutional investors and hedge funds.
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Further Reading
- Five stocks we like better than Amprius Technologies
- These Outperforming Giants Are Boosting Dividends in 2026, With Yields of Up to 6.6%
- Why Analysts Are Bullish on a Stock That’s Down 20%
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
